Pancreatic Cancer Research

ResearcherNiigata UniversityActive in the last 2 years

Toshifumi Wakai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2443-3428; OpenAlex author ID A5036289394. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
40
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: 2 papers · 2025: 1 paper

Papers 14

  1. Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal comparative study. Co-author DOI 10.1093/bjsopen/zraf026↗
  2. Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2024.10.001↗
  3. [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma-A Case Report]. Last author PMID 38247096↗
  4. Similarity of oncogenic protein expression in KRAS G12D gene delivery-based rat pancreatic cancer model to that of human pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2023.06.057↗
  5. Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.21873/anticanres.16584↗
  6. [Resectable Pancreatic Cancer Successfully Treated with Neoadjuvant Chemotherapy Regimen Change to Modified FOLFIRINOX-A Case Report]. Last author PMID 38303344↗
  7. [Total Pancreatectomy for Remnant Pancreatic Cancer with Positive Washing Cytology after Conversion to Negative Cytology Following Gemcitabine plus Nab-Paclita… Last author PMID 36733175↗
  8. [A Case of Long-Term Survival after Resection of Pancreatic Ductal Adenocarcinoma with Para-Aortic Lymph Node Metastasis]. Last author PMID 35045474↗
  9. [A Case of Umbilical Metastasis from Pancreatic Cancer after Surgery]. Last author PMID 33468977↗
  10. Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression. Last author DOI 10.1016/j.jss.2018.06.019↗
  11. [A Case of Long-Term Survival after Reoperation for Neck Lymph Node Metastasis Occurring Seven Years after Pancreaticoduodenectomy for Pancreatic Adenocarcinom… Last author PMID 30692448↗
  12. [Long-Term Survival after Reoperation for Lung Metastasis of Resected Pancreatic Adenocarcinoma - A Case Report]. Last author PMID 28133268↗
  13. Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo. First author DOI 10.18632/oncotarget.3584↗
  14. [A Case of Radical Resection for Locally Advanced Pancreatic Cancer with Positive Peritoneal Cytology Treated with Chemoradiotherapy]. Last author PMID 26805372↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuki Hirose · 10 shared papers, 2015–2025 · strength 1.16
  2. Kazuyasu Takizawa · 7 shared papers, 2015–2024 · strength 0.71
  3. Hiroki Nagaro · 3 shared papers, 2020–2023 · strength 0.37
  4. Aya Maekawa · 2 shared papers, 2024–2025 · strength 0.37
  5. Masato Ozaka · 2 shared papers, 2024–2025 · strength 0.37
  6. Atsushi Oba · 2 shared papers, 2024–2025 · strength 0.37
  7. Kojiro Omiya · 2 shared papers, 2024–2025 · strength 0.37
  8. Hiromichi Ito · 2 shared papers, 2024–2025 · strength 0.37
  9. Yu Takahashi · 2 shared papers, 2024–2025 · strength 0.37
  10. Naoki Sasahira · 2 shared papers, 2024–2025 · strength 0.37
  11. Kizuki Yuza · 5 shared papers, 2015–2020 · strength 0.33
  12. Hirosuke Ishikawa · 3 shared papers, 2016–2024 · strength 0.32
  13. Takuya Ando · 3 shared papers, 2016–2024 · strength 0.30
  14. Yoshihiro Ono · 1 shared paper, 2025 · strength 0.21
  15. Yosuke Inoue · 1 shared paper, 2025 · strength 0.21
  16. Takafumi Mie · 1 shared paper, 2025 · strength 0.21
  17. Keisuke Aizawa · 1 shared paper, 2024 · strength 0.18
  18. Osamu Shibata · 1 shared paper, 2023 · strength 0.17
  19. Yuto Tanaka · 1 shared paper, 2023 · strength 0.17
  20. Shuji Terai · 1 shared paper, 2023 · strength 0.17
  21. Yuki Kitano · 1 shared paper, 2024 · strength 0.16
  22. Takashi Sasaki · 1 shared paper, 2024 · strength 0.16
  23. Manabu Takamatsu · 1 shared paper, 2024 · strength 0.16
  24. Shoki Sato · 1 shared paper, 2024 · strength 0.16
  25. Tsuyoshi Takeda · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.